London (Parliament Politic Magazine) – Imperial College London Diabetes Centre and HealthPlus Diabetes and Endocrinology Center, both entities under the M42 umbrella, celebrated the successful initiation of the Mubadala Health Diabetes Conference on Saturday.
Timed to coincide with Diabetes Awareness Month and in preparation for World Diabetes Day on November 14th, the conference has brought together a distinguished group of international experts to delve into crucial aspects of diabetes management.
On the inaugural day of the event, esteemed global figures specializing in diabetes care took the stage to tackle vital issues associated with diabetes management. Renowned medical experts, recognized worldwide, imparted the latest advancements in diabetes care to the medical community through engaging talks and panel discussions.
The Breakthrough in Diabetes Health Care
Mohammed Al-Khatib, Conference Chairman and Medical Director, as well as an Internal Medicine, Diabetes, and Endocrinology Consultant at HealthPlus Diabetes and Endocrinology Center, kicked off the proceedings with an inspiring opening address. Stressing the significance of collaborative efforts for fostering innovation, he conveyed to the audience that the foremost minds in the industry had converged to propel advancements in diabetes care. He revealed:
It was my honor to welcome delegates to the conference today and as always, I am impressed by the calibre of attendees. Today’s sessions saw spirited debate and fresh, groundbreaking insights being aired.”Professor Maha Barakat, Assistant Minister for Health and Life Sciences at the UAE Ministry of Foreign Affairs, provided crucial insights into the latest updates in diabetes guidelines, setting the tone for evidence-based care.
The event holds substantial importance as an annual gathering dedicated to updating the diabetes community on the latest breakthroughs in diabetes healthcare. It covers a spectrum of critical aspects, including blood sugar management, complications, prevention and treatment strategies, gestational diabetes, and comprehensive care for patients spanning all age groups.
Management of Type 2 Diabetes
Karim Meeran, Professor of Endocrinology at Imperial College London, UK, skillfully moderated an engaging debate on the juxtaposition of technology and pharmacology in the management of Type 2 Diabetes during the twincretins era.
Simultaneously, Kevin Murphy, Professor of Endocrinology and Metabolism, also from Imperial College London, UK, shared his expertise on the significant influence of dietary choices on the treatment of type 2 diabetes, providing valuable insights to the captivated audience.
Our current emphasis is predominantly centered on exploring diabetes prevention through dietary manipulation, rather than relying on pharmaceutical intervention. In this context, we have amassed a substantial body of research that identifies foods conducive to effective glucose control. This research holds the promise of playing a preventive role in the onset of metabolic diseases in later stages of life. Moreover, our studies conducted right here in Abu Dhabi aim to unravel the impact of protein intake on enhancing insulin production.
Consequently, this research contributes to the effective management of blood glucose levels. Notably, our findings indicate that the response to protein remains effective in individuals with impaired fasting glucose tolerance, a population at risk of developing diabetes.
Therefore, incorporating this knowledge into dietary interventions may prove valuable in reducing their future disease risk. Our vision for the future is to empower patients to make informed dietary choices, offering a proactive approach in managing glucose levels. This, in turn, holds the potential to prevent diabetes and alleviate the risk of metabolic diseases.
Read More: Key Hurdles Confronting the Healthcare and Care Systems in England
Glucose Monitoring and Target Setting
Adam Buckley, Consultant Endocrinologist and Diabetologist at Imperial College London Diabetes Centre in Abu Dhabi, delved into the intricacies of glucose monitoring and target setting. His focus extended to situations where the reliability of HbA1c measurements may be questionable, particularly within the Gulf population.
Concluding the day’s events, Lyndon Marc Evans, Consultant Diabetologist at Cardiff University in the UK, delivered a presentation highlighting the interconnectivity of Cardio-Renal Metabolic conditions. He underscored the significance of holistic care, referencing the latest clinical evidence.
Looking ahead to Day Two of the conference, discussions will delve into topics including the prevention and treatment of Diabetic Kidney Disease, providing a comprehensive view of diabetes from an endocrine perspective.
This event serves as a pivotal platform for healthcare practitioners nationwide to come together in the collective effort against diabetes. It fosters the sharing of knowledge, the exchange of groundbreaking research, and crucial debates on effective strategies to tackle this prevalent health challenge.